Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 28, 2026Discover OncologyOpen Access

Recent advances in Ganoderma lucidum-derived bioactive components for cancer therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

XYXiangrong YinLiaocheng People's HospitalWLWei LiuYSYue SunHarbin Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yin et al. (2026) studied this question.

synapsesocial.com/papers/6ab9b5f27822ec8fc3d9146bhttps://doi.org/10.1007/s12672-026-06015-8
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Potential Active Compounds of Ganoderma lucidum and Their Anticancer Effects: A Comprehensive Review2025 · 9 citations
  2. 2The dual role of Ganoderma lucidum polysaccharides in cancer treatment: Meridian tropism-based direct inhibition and immune-mediated modulation2026
  3. 3Exploring the Therapeutic Potential of Ganoderma lucidum in Cancer2024 · 39 citations
  4. 4Antitumor Effects of Ganoderma lucidum polysaccharides and their Clinical Applications: An Updated Review2026 · 1 citations
  5. 5Ganoderma lucidum: A Medicinal Mushroom with Prebiotic and Anticancer Potential in Gastrointestinal Cancers2025 · 2 citations